Author

Jianfa Ou

Institution: Bristol-Myers Squibb (United States)

Observed institution: Bristol-Myers Squibb (United States)

ORCID: 0009-0003-5805-7544

Observed ORCID: 0009-0003-5805-7544

OpenAlex ID: A5004432771

Upstream cell culture process characterization and in-process control strategy development at pandemic speed

2022 · Jianlin Xu, Jianfa Ou, et al. · mAbs · 38

Recent advances in upstream process development for production of recombinant adeno‐associated virus

2023 · Jianfa Ou, Yawen Tang, et al. · Biotechnology and Bioengineering · 17

Impact of preparation pH and temperature on amino acid stability of highly concentrated cell culture feed media

2022 · Wanyue Cui, Jianfa Ou, et al. · Journal of Chemical Technology & Biotechnology · 8

Scalable process development for rAAV transient transfection production using computational fluid dynamics modeling

2025 · Jianfa Ou, Yawen Tang, et al. · Biotechnology Progress · 2

Use of spectroscopic process analytical technology for rapid quality evaluation during preparation of CHO cell culture media

2024 · Jianfa Ou, Wanyue Cui, et al. · Biotechnology Progress · 1

Author response for "Use of spectroscopic process analytical technology for rapid quality evaluation during preparation of CHO cell culture media"

2024 · Jianfa Ou, Wanyue Cui, et al. · Publons reviews and discussion

Works count: 6

Citation count: 66

H-index: 3

I10-index: 2